Identifying effective behavioural components of Intervention and Comparison group support provided in SMOKing cEssation (IC-SMOKE) interventions: A systematic review protocol

被引：25

作者：

de Bruin M. ^{[1
]}

Viechtbauer W. ^{[2
]}

Eisma M.C. ^{[1
]}

Hartmann-Boyce J. ^{[3
]}

West R. ^{[4
]}

Bull E. ^{[5
]}

Michie S. ^{[6
]}

Johnston M. ^{[1
]}

机构：

[1] University of Aberdeen, Aberdeen Health Psychology Group, Institute of Applied Health Sciences, Aberdeen, Scotland

[2] Maastricht University, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht

[3] University of Oxford, Nuffield Department of Primary Care Health Sciences, Oxford, England

[4] University College London, Health Behaviour Research Centre, Department of Epidemiology and Public Health, London, England

[5] NHS Grampian Public Health Directorate, Aberdeen, Scotland

[6] University College London, Research Department of Clinical, Educational and Health Psychology, London, England

来源：

Systematic Reviews | / 5卷 / 1期

基金：

英国经济与社会研究理事会; 英国医学研究理事会;

关键词：

Behaviour change technique; Comparison group; Control group; Intervention; Meta-analysis; Meta-regression; Randomized controlled trial; Smoking cessation; Systematic review; Tobacco;

D O I：

10.1186/s13643-016-0253-1

中图分类号：

学科分类号：

摘要：

Background: Systematic reviews of behaviour change interventions for smoking cessation vary in scope, quality, and applicability. The current review aims to generate more accurate and useful findings by (1) a detailed analysis of intervention elements that change behaviour (i.e. behaviour change techniques (BCTs)) and potential moderators of behaviour change (i.e. other intervention and sample characteristics) and (2) assessing and controlling for variability in support provided to comparison groups in smoking cessation trials. Methods: A systematic review will be conducted of randomized controlled trials of behaviour change interventions for smoking cessation in adults (with or without pharmacological support), with a minimum follow-up of 6 months, published after 1995. Eligible articles will be identified through the Cochrane Tobacco Addiction Group Specialized Register. Study authors will be asked for detailed descriptions of smoking cessation support provided to intervention and comparison groups. All data will be independently coded by two researchers. The BCT taxonomy v1 (tailored to smoking cessation interventions) and template for intervention description and replication criteria will be used to code intervention characteristics. Data collection will further include sample and trial characteristics and outcome data (smoking cessation rates). Multilevel mixed-effects meta-regression models will be used to examine which BCTs and/or BCT clusters delivered to intervention and comparison groups explain smoking cessation rates in treatment arms (and effect sizes) and what key moderators of behaviour change are. Predicted effect sizes of each intervention will be computed assuming all interventions are compared against comparison groups receiving the same levels of behavioural support (i.e. low, medium, and high levels). Multi-disciplinary advisory board members (policymakers, health care providers, and (ex-)smokers) will provide strategic input throughout the project to ensure the review's applicability to policy and practice. Discussion: By capturing BCTs in intervention and comparison groups, this systematic review will provide more accurate estimates of the effectiveness of smoking cessation interventions, the most promising BCTs and/or BCT clusters associated with smoking cessation rates in intervention and comparison arms, and important moderators of behaviour change. The results could set new standards for conducting meta-analyses of behaviour change interventions and improve research, service delivery, and training in the area of smoking cessation. Systematic review registration: PROSPERO CRD42015025251 © 2016 de Bruin et al.

引用

共 53 条

[1]

Peto R., Lopez A.D., Boreham J., Thun M., Heath C., Doll R., Mortality from smoking worldwide, Br Med Bull, (1996)

[2]

Adhikari B., Kahende J., Malacher A., Pechacek T., Tong V., Smoking-attributable mortality, years of potential life lost and productivity losses, Oncology Times, (2009)

[3]

Higgins J.P.T., Green S., Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011], (2011)

[4]

Abraham C., Michie S., A taxonomy of behavior change techniques used in interventions, Health Psychol, (2008)

[5]

Bruin M., Viechtbauer W., Schaalma H., Kok G., Abraham C., Hospers H., Standard care impact on effects of highly active antiretroviral therapy adherence interventions: a meta-analysis of randomized controlled trials, Arch Intern Med, (2010)

[6]

Michie S., Hyder N., Walia A., West R., Development of a taxonomy of behaviour change techniques used in individual behavioural support for smoking cessation, Addict Behav, (2011)

[7]

Michie S., Richardson M., Johnston M., Abraham C., Francis J., Hardeman W., Eccles M.P., Cane J., Wood C.E., The behavior change technique taxonomy (v1) of 93 hierarchically-clustered techniques: building an international consensus for the reporting of behavior change interventions, Ann Behav Med, (2013)

[8]

Bruin M., Viechtbauer W., Hospers H.J., Schaalma H.P., Kok G., Standard care quality determines treatment outcomes in comparator groups of HAART-adherence intervention studies: implications for the interpretation and comparison of intervention effects, Health Psychol, (2009)

[9]

Wagner G.J., Kanouse D.E., Assessing usual care in clinical trials of adherence interventions for highly active antiretroviral therapy, J Acq Immun Def Synd, (2003)

[10]

Peters G.J., Bruin M., Crutzen R., Everything should be as simple as possible, but no simpler: towards a protocol for accumulating evidence regarding the active content of health behaviour change interventions, Health Psychol Rev, (2015)

← 1 2 3 4 5 6 →